Posts Tagged: Affordable Care Act

Monopoly May End Soon!

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Behavioral and Social Issues Related to Accounting, Cost Accounting, Ethical Dilemma, Financial Accounting, Income Taxes, Intermediate Accounting, Managerial Accounting, Uncategorized.

According to the New York Times, the curtain is expected to come down next week on a monopoly for the anti-inflammatory medication, Humira, that has generated $114 billion in revenue for AbbVie just since the end of 2016. Questions: Source: Robbins, R. (2023). How a Drug Company Made $114 Billion by Gaming the U.S. Patent… Read more »

Submarine Patents: What is their Role?

Posted by & filed under Accounting Information Systems, Accounting Principles, Advanced Accounting, All Articles, Auditing, Cost Accounting, Ethical Dilemma, Financial Accounting, Intermediate Accounting, Managerial Accounting.

Humira and Enbrel are biologic drugs, composed of complex proteins made in living cells. Humira was the No. 1 selling biologic with $14 billion in global sales and Enbrel was the No. 3 biologic at $8.7 billion. Questions: 1. Approximately how much is the yearly price tag for these drugs per patient? 2. During the… Read more »